GenMont Biotech Incorporation (TPE:3164)
16.15
-0.10 (-0.62%)
Aug 4, 2026, 1:30 PM CST
-20.25% (1Y)
| Market Cap | 1.39B -19.8% |
| Revenue (ttm) | 390.95M +6.1% |
| Net Income | 44.89M +15.2% |
| EPS | 0.52 +15.6% |
| Shares Out | 86.01M |
| PE Ratio | 31.05 |
| Forward PE | n/a |
| Dividend | 0.80 (4.92%) |
| Ex-Dividend Date | Apr 8, 2026 |
| Volume | 55,456 |
| Open | 16.15 |
| Previous Close | 16.25 |
| Day's Range | 16.00 - 16.45 |
| 52-Week Range | 15.90 - 20.75 |
| Beta | 0.07 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 7, 2026 |